Strong sales growth and strategic …

• Revenue: USD 15.7 million, an increase of 13.1% compared to the previous year.

• Operating income: $ 2.1 million, an increase of 16.2% compared to the previous year.

• Net income: USD 1.9 million, an increase of 26.7% compared to the previous year or $ 0.21 per diluted share.

• Direct income from HomeCare: $ 14.1 million, an increase of 14.8% compared to the previous year.

• Gross profit: USD 12.2 million, 78.0% of net sales, compared to 74.8%.

• SG & A editions: USD 9.8 million, an increase of 17.2% compared to the previous year.

• Input tax income: 2.3 million US dollars.

• Cash position: 15.2 million US dollars on March 31, 2025.

• Share buyback: Shares worth 1.4 million USD bought back in the third quarter.

• Sales employee: 55 repetitions, compared to 51 in the previous year.

Appearance date: May 13, 2025

For the complete protocol of the earnings call, see the full profit call transcription.

• Electromed Inc (ELMD) reported the tenth quarter as a result of sales and net profit in the year against the previous year, with sales increased from 13.1% to $ 15.7 million.

• The company achieved an increase in net income by 26.7% compared to the previous year and reached USD 1.9 million or $ 0.21 per diluted share.

• Electromed Inc (ELMD) expanded its team from direct sales employees to 55, compared to 51 in the previous year, which contributed to higher sales and market range.

• The company started a successful program for the veteran administration of direct-to-consumer-outerach program and generated significant inclusion with 1,200 clicks and 1,100 side views.

• Electromed Inc (ELMD) has a strong cash position with $ 15.2 million in cash and without debt, strategic investments and a share buyback program of up to 5 million US dollars.

• SG&A expenditure rose by 17.2% to USD 9.8 million, mainly due to higher salaries and incentive to affect the future profitability.

• There was a decline in the hospital by 7.5% and a decline in other sales by 41.5%, which indicates potential challenges in the business sections without a homecare.

• In the nine months on March 31, 2025, the amount of money fell by $ 0.8 million compared to an increase in the previous year, partly due to the share returns.

• Electromed Inc (ELMD) stands from the current tariff situation of potential risks that could affect the supply chain, even though they are primarily based in the USA.

• The company is especially in the implementation of a new CRM system that could temporarily reduce productivity during the transition period.

Q: Can you comment on your approach to adding sales employees and your plans for the future expansion? A: James Cunniff, President and CEO, explained that Electromed is pursuing a conscious approach to adding sales employees in order to avoid commitment and to ensure effective territory management. They are already hiring for the next financial year and are planning to add another sales employee for their hospital business, whereby there are growth opportunities.